Company has initiated Phase I/II AFFINITY DUCHENNE™ trial of RGX-202 Company also enrolling newly active observational screening study, AFFINITY BEYOND, evaluating…
adminJanuary 23, 2023
Ahead of his swearing-in on Wednesday, Gov.-elect Wes Moore’s Cabinet is nearly complete. Moore announced his picks for nine additional…
adminJanuary 23, 2023
On December 19, 2022, the Department of Defense ("DOD") issued a proposed rule seeking to amend the Defense Federal Acquisition…
adminJanuary 23, 2023
Federal innovation and entrepreneurship initiatives would receive substantial new funding under the text of the omnibus spending bill shared on…
adminJanuary 23, 2023
Organizations across the globe are pivoting their workplace technology strategy and many employers are grappling with big questions about which…
adminJanuary 17, 2023
The BioHealth Capital Region (BHCR) and its life science ecosystem have a rich and deep history of pioneering scientific innovation,…
adminJanuary 17, 2023
A new year means new opportunities to grow your business. If you're one of the millions of resolution makers who…
adminJanuary 17, 2023
Norfolk biotech company Embody has racked up a bevy of accomplishments since it was founded in 2014 with just two…
adminJanuary 17, 2023
Sanofi has thrown its financial weight behind its venture capital unit, making a $750 million, multi-year commitment to enable the…
adminJanuary 17, 2023